NVNI:NASDAQNvni Group Limited Analysis
Data as of 2026-04-21 - not real-time
$1.31
Latest Price
8/10Risk
Risk Level: High
Executive Summary
Nvni Group Limited is trading well beneath its short‑term moving averages, signaling a bearish technical backdrop despite a modestly bullish MACD histogram and a neutral‑ish RSI. The price sits near a key support level while the 200‑day trend remains down, and volume has been tapering, underscoring weakening momentum. Fundamentally, the company is reporting negative earnings, a negative price‑to‑earnings multiple, and a book value per share that is below zero, indicating significant profitability challenges. The balance sheet shows a sizable debt load relative to cash, and cash flow from operations is negative, raising concerns about cash sustainability. Volatility is exceptionally high and beta exceeds the market, pointing to amplified price swings. Recent news of a major acquisition of a majority stake in Beyondsoft’s U.S. business adds a strategic growth narrative but also introduces execution risk. The market’s sentiment is in “Extreme Greed” mode, yet the stock’s current price is a fraction of its 52‑week high, suggesting a large upside potential if the acquisition delivers synergies. Liquidity is constrained with a low average daily volume and a decreasing volume trend, which could exacerbate price moves. Overall, the stock presents a paradox of high risk and potential reward, demanding careful timing and risk management.
Market Outlook
Short Term
< 1 yearCautious
Model confidence: 7/10
Key Factors
- price below short‑term moving averages
- decreasing volume trend
- negative earnings and cash flow
Medium Term
1–3 yearsNeutral
Model confidence: 6/10
Key Factors
- integration risk of the Beyondsoft acquisition
- potential improvement in revenue growth
- still elevated volatility and beta
Long Term
> 3 yearsPositive
Model confidence: 8/10
Key Factors
- significant upside relative to current price
- strategic expansion through acquisition
- potential turnaround if profitability improves
Key Metrics & Analysis
Financial Health
Revenue Growth6.50%
Profit Margin-53.75%
P/E Ratio-6.5
P/B Ratio-0.6
Op. Cash Flow$-11029000
Industry P/E37.0
Technical Analysis
TrendBearish
RSI51.2
Support$0.96
Resistance$1.68
MA 20$1.23
MA 50$1.32
MA 200$3.65
MACDBullish
VolumeDecreasing
Fear & Greed Index87.3
Valuation
Target Price$8.00
Upside/Downside510.69%
GradeUndervalued
TypeValue
Risk Assessment
Beta1.37
Volatility151.75%
Sector RiskHigh
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskHigh
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.